In this study, although FOXQ1 expression was not significantly changed under short-term sorafenib stimulation, it was significantly increased in cells with long-term stimulation and tolerance to sorafenib, which affected the sensitivity of hepatocellular carcinoma cells to sorafenib. The gene discussed is FOXQ1; the disease is hepatocellular carcinoma.